EMA: Response to TB CAB letter

EMA's response to TB CAB letter regarding conducting drug-drug interaction studies for bedaquiline (TMC207) and delamanid (OPC6783).

Read More →

Janssen seeks accelerated FDA approval for bedaquiline to treat MDR-TB

If approved by the FDA, bedaquiline would be the first drug with a new mechanism of action for TB in more than 40 years and the first and only one specifically indicated for MDR-TB.

Read More →

Former prisoner gets TB and takes Government to court

Dudley Lee was arrested in 1999 and spent the next four years in Pollsmoor Prison, while he was tried for fraud and other financial crimes. About 70 court appearances later, he was found not guilty. While in prison he became sick with TB.

Read More →

Otsuka: Response to TB CAB letter

Otsuka's response to TB CAB letter regarding pharmacokinetic studies, paediatric studies, and compassionate use of delamanid.

Read More →

New G20 austerity measures required to address tuberculosis

Six members of the G20 are among the 22 countries with the highest burden of tuberculosis: Brazil, China, India, Indonesia, Russia and South Africa.

Read More →

UNITAID approves US$ 30 million for innovative project to roll out ground-breaking tuberculosis test at reduced cost

Xpert, once introduced and widely scaled-up, is expected to dramatically reduce the diagnostic gaps for tuberculosis, in particular in its multi-drug resistant form, or associated with an HIV infection.

Read More →

Transforming the HIV/TB response: Defining the next 10 years

International consultation convened in conjunction with AIDS 2012
Date: 21 July 2012
Time: 09:00 – 17:00
Location: Rm. 202, Georgetown Law, 600 New Jersey Ave., NW, McDonough Hall, Washington, DC 20001

Read More →

Round table discussion: Activist engagement and community involvement in TB research

3rd Annual South African TB Conference, Durban 2012
Date: 14 June 2012
Time: 14h00 – 15h30
Location: Hall 3B

Read More →

Tackling TB: Expand access to and improve affordability of diagnostics and treatment

Statement by the Treatment Action Campaign, SECTION27, Médecins Sans Frontières and Oxfam.

Read More →

Janssen: Response to TB CAB letter

Janssen's response to TB CAB letter regarding pharmacokinetic studies, paediatric studies, and compassionate use of bedaquiline.

Read More →

Page 83 of 92 · Total posts: 10

←First 82 83 84 Last→